p62dok, a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210bcr-abl
A. Di Cristofano
, M. Niki
, M. Zhao
, F. G. Karnell
, B. Clarkson
, W. S. Pear
, L. Van Aelst
, P. P. Pandolfi
Research output: Contribution to journal › Article › peer-review
101Scopus
citations
Fingerprint
Dive into the research topics of 'p62dok, a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210bcr-abl'. Together they form a unique fingerprint.
Keyphrases
Pharmacology, Toxicology and Pharmaceutical Science